Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.

IF 12.4 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Xin Liang, Xiang Li, Yifei Yao, Xiaoqiu Dai
{"title":"Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.","authors":"Xin Liang, Xiang Li, Yifei Yao, Xiaoqiu Dai","doi":"10.20892/j.issn.2095-3941.2025.0625","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study was aimed at analyzing temporal trends in lung cancer mortality from 2013 to 2021, and projecting future trends until 2030.</p><p><strong>Methods: </strong>Mortality data were extracted from the China Causes of Death Surveillance Dataset, which covers 2.37 billion person-years. Age-standardized mortality rates (ASMRs) were calculated with Segi's world standard population. Joinpoint regression was used to analyze temporal trends, and linear regression was applied to assess changes in mean age at death. A Bayesian age-period-cohort model was used to project mortality trends through 2030. Contributions of risk factors and demographic changes (population size and age structure) to mortality trends were decomposed with the population split method.</p><p><strong>Results: </strong>From 2013 to 2021, the crude lung cancer mortality rate increased by 2.3% annually, whereas the ASMR remained stable overall but showed significant 2.9% annual declines during 2015 and 2021. The ASMRs in urban areas (-2.9% per year) and eastern regions (-1.5% per year) showed significant decreasing trends throughout the entire period. The mean age at death increased across all areas, and the largest increases were observed in rural areas. Deaths among people ≥65 years of age rose by 1.6%-5.6% during the entire period. Decomposition analysis indicated that the increased death counts were driven primarily by population aging (32%-43%) and population growth (8%-31%), whereas risk factors contributed negatively (-3% to -29%). Projections suggested that the number of lung cancer deaths will reach approximately 760,200 by 2030, with continued increases in the crude mortality rate but slight declines in the ASMR.</p><p><strong>Conclusions: </strong>The lung cancer burden in China shows marked regional disparities and challenges due to population aging. To further decrease lung cancer deaths, optimized allocation of medical resources, strengthened prevention and control of lung cancer risk factors, and integration of effective policies will be required.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13449714/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biology & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20892/j.issn.2095-3941.2025.0625","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study was aimed at analyzing temporal trends in lung cancer mortality from 2013 to 2021, and projecting future trends until 2030.

Methods: Mortality data were extracted from the China Causes of Death Surveillance Dataset, which covers 2.37 billion person-years. Age-standardized mortality rates (ASMRs) were calculated with Segi's world standard population. Joinpoint regression was used to analyze temporal trends, and linear regression was applied to assess changes in mean age at death. A Bayesian age-period-cohort model was used to project mortality trends through 2030. Contributions of risk factors and demographic changes (population size and age structure) to mortality trends were decomposed with the population split method.

Results: From 2013 to 2021, the crude lung cancer mortality rate increased by 2.3% annually, whereas the ASMR remained stable overall but showed significant 2.9% annual declines during 2015 and 2021. The ASMRs in urban areas (-2.9% per year) and eastern regions (-1.5% per year) showed significant decreasing trends throughout the entire period. The mean age at death increased across all areas, and the largest increases were observed in rural areas. Deaths among people ≥65 years of age rose by 1.6%-5.6% during the entire period. Decomposition analysis indicated that the increased death counts were driven primarily by population aging (32%-43%) and population growth (8%-31%), whereas risk factors contributed negatively (-3% to -29%). Projections suggested that the number of lung cancer deaths will reach approximately 760,200 by 2030, with continued increases in the crude mortality rate but slight declines in the ASMR.

Conclusions: The lung cancer burden in China shows marked regional disparities and challenges due to population aging. To further decrease lung cancer deaths, optimized allocation of medical resources, strengthened prevention and control of lung cancer risk factors, and integration of effective policies will be required.

2013 - 2021年中国肺癌死亡率趋势及2030年预测
目的:本研究旨在分析2013年至2021年肺癌死亡率的时间趋势,并预测到2030年的未来趋势。方法:死亡率数据提取自中国死亡原因监测数据集,覆盖23.7亿人年。年龄标准化死亡率(ASMRs)用Segi世界标准人口计算。采用连接点回归分析时间趋势,采用线性回归评估平均死亡年龄的变化。使用贝叶斯年龄-时期-队列模型来预测到2030年的死亡率趋势。采用人口分裂法对危险因素和人口结构变化(人口规模和年龄结构)对死亡率趋势的贡献进行了分解。结果:2013 - 2021年,肺癌粗死亡率年均增长2.3%,而ASMR总体保持稳定,但2015 - 2021年年均下降2.9%。城市地区(-2.9% /年)和东部地区(-1.5% /年)的asmr在整个时期呈显著下降趋势。所有地区的平均死亡年龄都有所增加,其中农村地区的增幅最大。在整个期间,65岁以上人群的死亡率上升了1.6%-5.6%。分解分析表明,死亡人数的增加主要是由人口老龄化(32%-43%)和人口增长(8%-31%)驱动的,而风险因素则起到负作用(-3%至-29%)。预测表明,到2030年,肺癌死亡人数将达到约760 200人,粗死亡率继续上升,但ASMR略有下降。结论:由于人口老龄化,中国肺癌负担呈现明显的区域差异和挑战。进一步降低肺癌死亡,需要优化医疗资源配置,加强肺癌危险因素防控,整合有效政策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Biology & Medicine
Cancer Biology & Medicine Medicine-Oncology
CiteScore
9.80
自引率
3.60%
发文量
1143
审稿时长
12 weeks
期刊介绍: Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书